Changes in pneumococcal serotypes and antimicrobial resistance after introduction of the 13-Valent conjugate vaccine in the United States

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 11, 2014, Pages 6484-6489

  Richter, Sandra S ^a   Diekema, Daniel J ^b   Heilmann, Kristopher P ^b   Dohrn, Cassie L ^b   Riahi, Fathollah ^b   Doern, Gary V ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFTAROLINE; CEFTRIAXONE; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE; 13-VALENT PNEUMOCOCCAL VACCINE; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE; VACCINE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BROTH DILUTION; CHILD; FEMALE; HUMAN; INFANT; LONGITUDINAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MULTIPLEX POLYMERASE CHAIN REACTION; NEWBORN; NONHUMAN; PNEUMOCOCCAL INFECTION; SEROTYPE; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; VACCINATION; CLASSIFICATION; DRUG EFFECTS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PNEUMOCOCCAL INFECTIONS;

ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; LONGITUDINAL STUDIES; MICROBIAL SENSITIVITY TESTS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROGROUP; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; VACCINES, CONJUGATE;

EID: 84908587319     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.03344-14     Document Type: Article

References (19)

1. Thigpen MC, Whitney CG, Messonnier NE, Zell ER, Stat M, Lynfield R, Hadler JL, Harrison LH, Farley MM, Reingold A, Bennett NM, Craig AS, Schaffner W, Thomas A, Lewis MM, Scallan E, Schuchat A. 2011. Bacterial meningitis in the United States,1998-2007. N. Engl. J. Med. 364: 2016-2025. http://dx.doi.org/10.1056/NEJMoa1005384.
2. Fischer Walker CL, Rudan I, Liu L, Nair H, Theodoratou E, Bhutta ZA, O'Brien KL, Campbell H, Black RE. 2013. Global burden of childhood pneumonia and diarrhoea. Lancet 381:1405-1416. http://dx.doi.org/10.1016/S0140-6736(13)60222-6.
3. Doern GV, Heilmann KP, Huynh HK, Rhomberg PR, Coffman SL, Brueggemann AB. 2001. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-95. Antimicrob. Agents Chemother. 45:1721-1729. http://dx.doi.org/10.1128/AAC.45.6 .1721-1729.2001.
4. Whitney CG, Farley MM, Hadler J, Harrison LH, Lexau C, Reingold A, Lefkowitz L, Cieslak PR, Cetron M, Zell ER, Jorgensen JH, Schuchat A, Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. 2000. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N. Engl. J. Med. 343:1917-1924. http://dx.doi.org/10.1056/NEJM200012283432603.
5. Hsu HE, Shutt KA, Moore MR, Beall BW, Bennett NM, Craig AS, Farley MM, Jorgensen JH, Lexau CA, Petit A, Reingold A, Schaffner W, Thomas A, Whitney CG, Harrison LH. 2009. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N. Engl. J. Med. 360: 244-256. http://dx.doi.org/10.1056/NEJMoa0800836.
6. Kyaw MH, Lynfiekld R, Schaffner W, Craig AS, Hadler J, Reingold A, Thomas AR, Harrison LH, Bennett NM, Farley MM, Facklam RR, Jorgensen JH, Besser J, Zell ER, Schuchat A, Whitney CG. 2006. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N. Engl. J. Med. 354:1455-1463. http://dx.doi.org/10.1056/NEJMoa051642.
7. Richter SS, Heilmann KP, Dohrn CL, Riahi F, Diekema DJ, Doern GV. 2013. Pneumococcal serotype before and after introduction of conjugate vaccines, United States, 1999-2011. Emerg. Infect. Dis. 19:1074-1083. http://dx.doi.org/10.3201/eid1907.121830.
8. Pai R, Gertz RE, Beall B. 2006. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J. Clin. Microbiol. 44:124-131. http://dx.doi.org/10.1128/JCM.44.1.124-131.2006.
9. Richter SS, Heilmann KP, Dohrn CL, Riahi F, Diekema DJ, Doern GV. 2013. Evaluation of pneumococcal serotyping by multiplex PCR and quelling reactions. J. Clin. Microbiol. 51:4193-4195. http://dx.doi.org/10.1128/JCM.01876-13.
10. Clinical and Laboratory Standards Institute. 2012. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 8th ed. CLSI document M7-A9. Clinical and Laboratory Standards Institute, Wayne, PA.
11. Clinical and Laboratory Standards Institute. 2014. Performance standards for antimicrobial susceptibility testing; 24th informational supplement. CLSI document M100-S24. Clinical and Laboratory Standards Institute, Wayne, PA.
12. Doern GV, Diekema DJ, Heilmann KP, Dohrn CL, Riahi F, Richter SS. 2012. In vitro activity of ceftaroline against clinical isolates of Streptococcus pneumoniae recovered in 43 U.S. medical centers during 2010-2011. Antimicrob. Agents Chemother. 56:3406-3408. http://dx.doi.org/10.1128/AAC.00582-12.
13. Centers for Disease Control and Prevention. 2014. Active bacterial core surveillance (ABCs) report. Emerging Infections Program Network, Streptococcus pneumoniae. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/abcs/reports-findings/surv-reports.html.
14. Weinberger DM, Harboe ZB, Sanders EAM, Ndiritu M, Klugman KP, Ruckinger S, Dagan R, Adegbola R, Cutts F, Johnson HL, O'Brien KL, Scott JA, Lipsitch M. 2010. Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin. Infect. Dis. 51:692-699. http://dx.doi.org/10.1086/655828.
15. Imohl M, Reinert RR, Ocklenburg C, van der Linden M. 2010. Association of serotypes of Streptococcus pneumoniae with age in invasive disease. J. Clin. Microbiol. 48:1291-1296. http://dx.doi.org/10.1128/JCM .01937-09.
16. Beall B, McEllistrem CM, Gertz RE, Boxrud DJ, Besser JM, Harrison LH, Jorgensen JH, Whitney CG. 2002. Emergence of a novel penicillinnonsusceptible, invasive serotype 35B clone of Streptococcus pneumoniae within the United States. J. Infect. Dis. 186:118-122. http://dx.doi.org/10.1086/341072.
17. Kasahara K, Komatsu Y, Koizumi A, Chang B, Ohnishi M, Muratani T, Mikasa K. 2014. Serotype 35B Streptococcus pneumoniae in Japan, 2002-2012. J. Infect. Chemother. 20:228-230. http://dx.doi.org/10.1016/j.jiac .2013.11.008.
18. Steens A, Bergsaker MA, Aaberge IS, Ronning K, Vestrheim DF. 2013. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway. Vaccine 31:6232-6238. http://dx.doi.org/10.1016/j .vaccine.2013.10.032.
19. Jacobs MR, Good CE, Windau AR, Bajaksouzian S, Biek D, Critchley IA, Sader HS, Jones RN. 2010. Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States. Antimicrob. Agents Chemother. 54:2716-2719. http://dx.doi.org/10.1128/AAC.01797-09.